List of works - Marco Puzzoni

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review

scientific article published on 22 July 2017

BRAF-mutant colorectal cancer, a different breed evolving

scientific article published on 09 May 2018

Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy

scientific article published on 10 October 2017

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh)

scientific article published on 19 September 2017

Immunotherapy for colorectal cancer: where are we heading?

scientific article

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

scientific article published on 05 April 2017

Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy.

scientific article published on May 2016

Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials

article

Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study

scientific article published on 08 June 2018

Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link?

scientific article published on 3 May 2017

Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?

scientific article published on 20 April 2017

The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?

scientific article published on 17 May 2016

The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors

scientific article published on 15 May 2015

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.

scientific article published on 20 June 2017

Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications

scientific article published on 25 November 2016

[Cancer cachexia assessment: new tools for oncologists.]

scientific article published on 01 October 2016

List of works by Marco Puzzoni